$ACMR

Wang David H sold $173K of ACMR

Wang David H (See Remarks) sold 2,060 shares of ACM Research, Inc. (ACMR) at $83.86 ($0.17M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosed sale reduces insider holdings from 840,650 shares post-transaction, but provides no new operational/financial catalyst.

02

Market read

A single, planned insider sale is generally a low-impact catalyst unless it’s part of a broader pattern or accompanied by other negative news.

03

What to watch

The filing doesn’t reveal motives, and the sale is pre-arranged; without follow-on buys/sales patterns, signal quality is low.

Relevance 6/10Novelty 4/10Timing: Filed after-hours (2026-06-05 20:30 UTC) for a sale executed on 2026-06-04.

Background

SEC Form 4 disclosures report insider transactions; 10b5-1 plans are pre-scheduled to mitigate timing-based trading concerns.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider (officer/director/10% owner) sold 2,060 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Likely limited immediate impact; any effect would be sentiment-driven and small unless paired with other negative news.

Evidence & confidence

The filing is an SEC Form 4 for a planned 10b5-1 sale, which reduces the informational content versus an unplanned sale.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Even 10b5-1 sales can coincide with periods of perceived valuation risk; traders may still fade strength if selling volume is persistent.

Key entities

  • ACM Research, Inc.

    Issuer of the insider transaction disclosed via SEC Form 4.

  • Wang David H

    Officer/Director/10% Owner who executed an open-market sale under a 10b5-1 plan.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.